Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Journal of Medicinal Chemistry|June 29, 2017
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer CellsJian Min, Valeria Sanabria Guillen, Abhishek Sharma, et al.Cancer Research|September 15, 2017
Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and TumorsYuechao Zhao, Mary J Laws, Valeria Sanabria Guillen, et al.Annals of Hematology|January 9, 2023
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective studyYingying Shen, Qi Liu, Hangchao Li, et al.Nature Chemical Biology|November 22, 2016
Full antagonism of the estrogen receptor without a prototypical ligand side chainSathish Srinivasan, Jerome C Nwachukwu, Nelson E Bruno, et al.NPJ Breast Cancer|December 10, 2019
Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compoundsYvonne Ziegler, Mary J Laws, Valeria Sanabria Guillen, et al.Journal of Experimental & Clinical Cancer Research : CR|August 29, 2019
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAsYuechao Zhao, Yiran Li, Jie Sheng, et al.Nature Communications|August 25, 2015
Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathwayWei Song, Wenjie Liu, Hong Zhao, et al.Journal of Experimental & Clinical Cancer Research : CR|August 5, 2020
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activationXiaojuan Wang, Fan Wu, Han Wang, et al.Pageof 9